More than half a year has passed since the global pandemic wreaked havoc in societies and financial markets worldwide. Regrettably, the virus remains virulent so has slowed the pace of economic recovery and caused a multitude of social implications to remain prominent. The path towards a vaccine seems promising, with more than 130 projects globally, funded almost limitlessly, with accelerated clinical trial processes. A rapid rebound in consumer confidence and associated economic activity is expected should a successful vaccine become widely available.

There is no shortage of information, advice and opinion in newspapers, magazines and on the airwaves about successful investing – what to invest in, how to do it, what to avoid – but separating the good advice from the questionable advice is difficult. How do investors cut through to what really matters?